Related Experiment Videos
Differentiation induced by RB expression and apoptosis induced by p53 expression in an osteosarcoma cell line
K Ookawa1, S Tsuchida, J Adachi
1Second Department of Biochemistry, Hirosaki University School of Medicine, Aomori, Japan.
Abstract:
Multiple genetic alterations, including concurrent inactivation of RB and p53, occur frequently in several human cancers. To investigate the biological significance of RB and p53 gene inactivations, a wild-type RB or p53 cDNA expression vector regulated by tetracycline was introduced by stable transfection into an osteosarcoma cell line Saos-2, in which both the RB and p53 genes were inactivated. Induction of introduced RB expression resulted in suppression of cell growth, increased percentage of cells at the G0/G1 phase, and enlargement of the cells. Furthermore, activity of alkaline phosphatase was increased and expression of fibronectin was decreased, suggesting the induction of cell differentiation by RB expression. Induction of p53 expression also resulted in significant suppression of cell growth with slight accumulation of cells at the G0/G1 and G2/M phases. The cells were detached from culture dishes and the dead cell fraction increased. Furthermore, condensation of chromatin and DNA fragmentation were observed, suggesting the induction of apoptosis by p53. These results suggest that RB and p53 play different roles in carcinogenesis of osteoblast; RB inactivation releases cells from G0/G1 arrest and suppresses cell differentiation while p53 inactivation assists the cells to proliferate by repressing both apoptosis and cell cycle arrest at G0/G1 and G2/M.
Insights
RB and p53 gene inactivation impacts human osteosarcoma cell behavior differently. RB loss promotes differentiation and cell cycle progression, while p53 loss induces apoptosis and cell death.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Biology
Background:
- Concurrent inactivation of RB and p53 genes is common in human cancers.
- Understanding the distinct roles of RB and p53 in osteosarcoma is crucial for targeted therapies.
Purpose of the Study:
- To investigate the individual biological significance of RB and p53 gene inactivation in osteosarcoma.
- To elucidate the specific cellular processes regulated by RB and p53 in Saos-2 osteosarcoma cells.
Main Methods:
- Stable transfection of Saos-2 cells (inactivated RB and p53) with tetracycline-regulated wild-type RB or p53 cDNA expression vectors.
- Analysis of cell growth, cell cycle phase distribution (G0/G1, G2/M), cell differentiation markers (alkaline phosphatase, fibronectin), apoptosis markers (chromatin condensation, DNA fragmentation), and cell detachment.
Main Results:
- RB expression induction suppressed cell growth, increased G0/G1 phase cells, induced cell enlargement, elevated alkaline phosphatase activity, and decreased fibronectin expression, indicating RB promotes differentiation.
- p53 expression induction significantly suppressed cell growth, caused slight G0/G1 and G2/M phase accumulation, induced cell detachment, increased cell death, chromatin condensation, and DNA fragmentation, indicating p53 induces apoptosis.
- RB and p53 play distinct roles: RB inactivation releases cells from G0/G1 arrest and inhibits differentiation; p53 inactivation promotes proliferation by repressing apoptosis and cell cycle arrest.
Conclusions:
- RB and p53 have divergent roles in osteoblast carcinogenesis.
- RB inactivation contributes to cancer progression by promoting cell cycle entry and suppressing differentiation.
- p53 inactivation facilitates proliferation by inhibiting apoptosis and cell cycle arrest, highlighting their importance as tumor suppressors.